Apatinib monotherapy for advanced VEGFR-2-negative nasopharyngeal carcinoma: A case report

RATIONALE: Due to the anatomical and biological characteristics of nasopharyngeal carcinoma (NPC), radiotherapy is the standard treatment of choice. Recent advances in small molecule therapies targeting tumor angiogenesis also hold promise for the treatment of advanced NPC. PATIENT CONCERNS: The pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Jun, Du, Jiahao, Wu, Yanwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344178/
https://www.ncbi.nlm.nih.gov/pubmed/30608382
http://dx.doi.org/10.1097/MD.0000000000013491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344178/
https://www.ncbi.nlm.nih.gov/pubmed/30608382
http://dx.doi.org/10.1097/MD.0000000000013491

Ejemplares similares